(Webinar date: June 25, 2018) The federal deadline is approaching for all Rx products to be marked by new Global Trade Item Numbers (GTINs), the crucial identifier that links a scan of a barcode to the data associated with that product.
With Drug Supply Chain Security Act (DSCSA) enforcement discretion coming to an end, manufacturers will be introducing serialized products into the market by November 27, 2018. Now is the time to begin sharing this information — are you prepared to notify other supply chain stakeholders that these products are on their way? HDA, in partnership with ValueCentric, has developed an easy and cost-effective solution to manage the communication of new GTINs in one place and at one time, through Origin — a high-powered, central data repository, hosting verified GTIN information.
Join us for HDA’s a complimentary webinar to review the key features and benefits of Origin, which enables the secure, accurate and efficient exchange of pharmaceutical product master data between manufacturers and their supply chain trading partners to help comply with the DSCSA. Origin’s concept is straightforward: manufacturers and repackagers (“contributors”) populate GTIN data into Origin and downstream trading partners (distributors and dispensers or “consumers”) can download that information into their master data systems. This ensures that manufacturers can simultaneously reach direct and indirect downstream trading partners when they introduce current or new products with serial numbers, make packaging changes that require a new GTIN, acquire or divest products and more.
Perry Fri, Executive Vice President, Industry Relations, Membership and Education, HDA
Drew Neil, Director, Enterprise Architecture DSCSA, ValueCentric, LLC
Dianne Pfahl, Vice President, Strategic Sourcing National Brands, Cardinal Health, Inc.
For product details, visit the Origin product website.